PremiumRatingsJNJ: Strong Innovative Medicine Drives Guidance Raise but Mixed MedTech Keeps Risk/Reward Balanced, Supporting Hold Rating1d agoJNJ
JNJ: Strong Innovative Medicine Drives Guidance Raise but Mixed MedTech Keeps Risk/Reward Balanced, Supporting Hold Rating